Cite

HARVARD Citation

    Klein, P. et al. (n.d.). I01 QRX-704, a novel antisense oligonucleotide therapy, designed to prevent hd pathology while maintaining htt function. Journal of neurology, neurosurgery and psychiatry. p. A88. [Online]. 
  
Back to record